Wegovy Injection Recall Due to Hair in Prefilled Syringe
Novo Nordisk is recalling specific lots of Wegovy (semaglutide) injection because hair was found in prefilled syringes. Affected patients should contact their healthcare provider before using remaining doses.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II FDA recall of an injectable drug with particulate matter contamination. No illnesses or injuries have been reported. It meets the Score 3 (High) threshold as a risk-of-harm injectable product where injury has not yet been reported.
Plain-English summary
Novo Nordisk Inc. is recalling Wegovy (semaglutide) Injection, 1 mg/0.5 mL prefilled pens because hair has been found in a prefilled syringe. The affected lots are RZFYK06 and RZFYA53, both expiring March 31, 2027. These lots were distributed nationwide within the United States.
Wegovy is a prescription injection used for weight management. The presence of particulate matter in an injectable product poses a potential risk of harm to patients who may inadvertently inject the contaminated medication.
Patients with affected lots should discontinue use and contact their healthcare provider immediately before injecting any remaining doses. Consumers and healthcare providers who have experienced adverse events related to this recall are encouraged to report them to the FDA's MedWatch program.
No illnesses or injuries have been reported to date in connection with this contamination.
The recalled product
- Product
- WEGOVY (SEMAGLUTIDE)
- Brand
- WEGOVY
- Manufacturer
- Novo Nordisk Inc.
- Category
- Drug — Prescription Injectable
- Hazard
- particulate-matter
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: RZFYK06
- RZFYA53
- Exp Date 3/31/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · WEGOVY
- HighNovo Nordisk Recalls Wegovy Semaglutide Injection Pens for Hair Contamination
FDA (Drugs) · 2026-01-07
- HighWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27